@article{5a4ec8cb-b729-438b-b170-1a21d381fba1,
author = {Tomasz  Hermanowski, Sylwia I. Szafraniec-Buryło, Aleksandra N.  Krancberg, Dominika Dulęba, Urszula  Cegłowska},
title = {Availability and quality of data on drug policy and management  of access to reimbursed medicinal products in the United Kingdom, Denmark, Germany, Italy and Poland},
journal = {Zdrowie Publiczne i Zarządzanie},
volume = {2013},
number = {Tom 11, Numer 1},
year = {2013},
issn = {1731-7398},
pages = {89-99},keywords = {dostępność danych; jakość; ocena metodologii; proces decyzyjny},
abstract = {Objectives: To perform a systematic review, and to verify and define deficiencies in literature data on drug policy and management of access to reimbursed medicinal products in the United Kingdom, Denmark, Germany, Italy and Poland as a source of information intended to be used by government authorities in the decision-making process.
	Methods: A systematic review was conducted through database search of Medline, SCOPUS, Embase and Cochrane Library, supplemented by nonsystematic review. The quality of the identified literature was critically appraised.
	Results: Information necessary to develop a knowledge base was outline from 121 papers identified through database search. 0.83% of all publications were rated high in all of the assessed categories, i.e. were identified to represent high levels of consistency, coherence, strength and methodological quality.
	Conclusions: In the policy decision-making process, concise recommendations based on validated data are more than needed. It is vital to rely on scientific evidence and avoid reports based on simple exchange of information or presenting single-source or unconfirmed data, including expert’s opinion.},
doi = {10.4467/20842627OZ.14.009.1619},
url = {https://ejournals.eu/czasopismo/zdrowie-publiczne-i-zarzadzanie/artykul/availability-and-quality-of-data-on-drug-policy-and-management-of-access-to-reimbursed-medicinal-products-in-the-united-kingdom-denmark-germany-italy-and-poland}
}